173 related articles for article (PubMed ID: 17172586)
1. Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders.
Zigmond E; Preston S; Pappo O; Lalazar G; Margalit M; Shalev Z; Zolotarov L; Friedman D; Alper R; Ilan Y
Gut; 2007 Jan; 56(1):82-9. PubMed ID: 17172586
[TBL] [Abstract][Full Text] [Related]
2. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
[TBL] [Abstract][Full Text] [Related]
3. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
Ilan Y; Ohana M; Pappo O; Margalit M; Lalazar G; Engelhardt D; Rabbani E; Nagler A
Transplantation; 2007 Feb; 83(4):458-67. PubMed ID: 17318079
[TBL] [Abstract][Full Text] [Related]
4. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
5. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution.
Safadi R; Zigmond E; Pappo O; Shalev Z; Ilan Y
Int Immunol; 2007 Aug; 19(8):1021-9. PubMed ID: 17698563
[TBL] [Abstract][Full Text] [Related]
7. Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Oncology; 2004; 66(4):323-30. PubMed ID: 15218301
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis.
Shibolet O; Kalish Y; Klein A; Alper R; Zolotarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Leukoc Biol; 2004 Jan; 75(1):76-86. PubMed ID: 14557387
[TBL] [Abstract][Full Text] [Related]
9. Decreased STAT-1 phosphorylation by a thio analogue of beta-D-glucosylceramide is associated with altered NKT lymphocyte polarization.
Ben Ya'acov A; Lalazar G; Livovsky DM; Kanovich D; Axelrod E; Preston S; Schwarzmann G; Ilan Y
Mol Immunol; 2009 Dec; 47(2-3):526-33. PubMed ID: 19818503
[TBL] [Abstract][Full Text] [Related]
10. NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta-glycosphingolipids.
Zigmond E; Shalev Z; Pappo O; Alper R; Zolotarov L; Ilan Y
J Autoimmun; 2008 Sep; 31(2):188-95. PubMed ID: 18710796
[TBL] [Abstract][Full Text] [Related]
11. Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping.
Lalazar G; Ben Ya'acov A; Eliakim-Raz N; Livovsky DM; Pappo O; Preston S; Zolotarov L; Ilan Y
J Lipid Res; 2008 Sep; 49(9):1884-93. PubMed ID: 18480029
[TBL] [Abstract][Full Text] [Related]
12. Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination.
Mizrahi M; Lalazar G; Ben Ya'acov A; Livovsky DM; Horowitz Y; Zolotarov L; Adler R; Shouval D; Ilan Y
Vaccine; 2008 May; 26(21):2589-95. PubMed ID: 18423947
[TBL] [Abstract][Full Text] [Related]
13. Administration of beta-glycolipids overcomes an unfavorable nutritional dependent host milieu: a role for a soy-free diet and natural ligands in intrahepatic CD8+ lymphocyte trapping and NKT cell redistribution.
Livovsky DM; Lalazar G; Ben Ya'acov A; Pappo O; Preston S; Zolotaryova L; Ilan Y
Int Immunopharmacol; 2008 Sep; 8(9):1298-305. PubMed ID: 18602077
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic CD8(+) lymphocyte trapping during tolerance induction using mushroom derived formulations: a possible role for liver in tolerance induction.
Shuvy M; Hershcovici T; Lull-Noguera C; Wichers H; Danay O; Levanon D; Zolotarov L; Ilan Y
World J Gastroenterol; 2008 Jun; 14(24):3872-8. PubMed ID: 18609712
[TBL] [Abstract][Full Text] [Related]
15. Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes.
Margalit M; Abu Gazala S; Alper R; Elinav E; Klein A; Doviner V; Sherman Y; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G917-25. PubMed ID: 15976388
[TBL] [Abstract][Full Text] [Related]
16. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A
Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping.
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Pathol; 2006 May; 209(1):121-8. PubMed ID: 16482497
[TBL] [Abstract][Full Text] [Related]
18. Immune modulation of ovalbumin-induced lung injury in mice using β-glucosylceramide and a potential role of the liver.
Horani A; Shoseyov D; Doron S; Mruwat R; Amer J; Kerem E; Safadi R
Immunobiology; 2011 May; 216(5):548-57. PubMed ID: 21074892
[TBL] [Abstract][Full Text] [Related]
19. Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis.
El Haj M; Ben Ya'acov A; Lalazar G; Ilan Y
World J Gastroenterol; 2007 Nov; 13(44):5799-804. PubMed ID: 17990345
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking.
Gur C; Karussis D; Golden E; Doron S; Ilan Y; Safadi R
Clin Immunol; 2006; 118(2-3):307-16. PubMed ID: 16290121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
